This week 7 webinars: PFAS Method Development, Plasma proteomics, MOSH & MOAH, Clarity 10 SW, Clinical cancer cohorts, Gas Supply, Sample tracking.
Mo, 3.2.2025
LabRulez
Scientific article | Various
Synthesis and absolute configuration of cyclic synthetic cathinones derived from α-tetralone
The goal of this study is to design, synthesize, and characterize novel cyclic α-tetralone-based synthetic cathinones and determine their absolute configurations.
Tu, 28.1.2025
LabRulez
Article | Webinars
Webinars LabRulezLCMS Week 5/2025
This week 4 webinars: Testing of Balances and Scales, PFAS in Foods, DirectInject-LC Virtual User Forum, Why You Need To Look at Your Spectra?
Mo, 27.1.2025
LabRulez
Article | Application
News from LabRulezLCMS Library - Week 4, 2025
This week we bring you documents by Shimadzu, Agilent Technologies, Thermo Fisher Scientific, Metrohm, and Waters Corporation.
We, 22.1.2025
LabRulez
Scientific article | Various
Personalized Profiling of Lipoprotein and Lipid Metabolism Based on 1018 Measures from Combined Quantitative NMR and LC-MS/MS Platforms
The goal of this study is to integrate and analyze large-scale lipoprotein and lipidomics data for understanding molecular epidemiology and cardiometabolic risk.
Tu, 21.1.2025
LabRulez
Scientific article | Various
Evaluation of ion pairing reversed-phase liquid chromatography for the separation of large RNA molecules
The goal of this study is to optimize IP-RPLC for separating and characterizing large RNA molecules, enhancing RNA quality attribute analysis for therapeutic development.
This week we bring you documents by Thermo Fisher Scientific, Agilent Technologies, Shimadzu, Metrohm, and Waters Corporation.
We, 15.1.2025
LabRulez
Scientific article | Various
Understanding the fundamentals of the on-off retention mechanism of oligonucleotides and their application to high throughput analysis
The goal of this study is to investigate oligonucleotide elution behavior in IP-RPLC under various mobile phase conditions and develop ultra-fast separation methods for therapeutic oligonucleotides.